CN104381991A - Ganoderma lucidum sporoderm-broken spore powder capsule and preparation method thereof - Google Patents
Ganoderma lucidum sporoderm-broken spore powder capsule and preparation method thereof Download PDFInfo
- Publication number
- CN104381991A CN104381991A CN201310359889.8A CN201310359889A CN104381991A CN 104381991 A CN104381991 A CN 104381991A CN 201310359889 A CN201310359889 A CN 201310359889A CN 104381991 A CN104381991 A CN 104381991A
- Authority
- CN
- China
- Prior art keywords
- powder
- capsule
- ganoderma
- lucidum
- dextrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 73
- 239000002775 capsule Substances 0.000 title claims abstract description 35
- 240000008397 Ganoderma lucidum Species 0.000 title claims abstract description 19
- 235000001637 Ganoderma lucidum Nutrition 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 36
- 229920001353 Dextrin Polymers 0.000 claims abstract description 21
- 239000004375 Dextrin Substances 0.000 claims abstract description 21
- 235000019425 dextrin Nutrition 0.000 claims abstract description 21
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 14
- 238000011049 filling Methods 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 238000005498 polishing Methods 0.000 claims abstract description 4
- 241000222336 Ganoderma Species 0.000 claims description 61
- 238000012856 packing Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 235000009508 confectionery Nutrition 0.000 claims description 10
- 239000011812 mixed powder Substances 0.000 claims description 6
- 230000002950 deficient Effects 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 12
- 230000036039 immunity Effects 0.000 abstract description 10
- 206010028980 Neoplasm Diseases 0.000 abstract description 6
- 230000036737 immune function Effects 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000009758 senescence Effects 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 238000005303 weighing Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 230000006870 function Effects 0.000 description 9
- 241000207961 Sesamum Species 0.000 description 6
- 235000003434 Sesamum indicum Nutrition 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 3
- RDMQPKIDHAFXKA-JNORPAGFSA-N Ganoderic Acid Am1 Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC(=O)C1=C2C(=O)C[C@]2(C)[C@@H]([C@@H](CC(=O)CC(C)C(O)=O)C)CC(=O)[C@]21C RDMQPKIDHAFXKA-JNORPAGFSA-N 0.000 description 3
- 229930182735 Ganoderic acid Natural products 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 150000003648 triterpenes Chemical class 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010061598 Immunodeficiency Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000003471 anti-radiation Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000007661 gastrointestinal function Effects 0.000 description 2
- 229910052732 germanium Inorganic materials 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000005760 tumorsuppression Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 206010001513 AIDS related complex Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001489091 Ganoderma sinense Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000446313 Lamella Species 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a ganoderma lucidum sporoderm-broken spore powder capsule which comprises raw materials and auxiliary materials. The raw materials contain the following ingredients, by weight, 65-75 parts of a ganoderma lucidum extract and 145-155 parts of ganoderma lucidum sporoderm-broken spore powder. The auxiliary materials contain the following ingredients, by weight, 170-185 parts of dextrin and 1.5-2.5 parts of silicon dioxide. The invention also discloses a preparation method of the ganoderma lucidum sporoderm-broken spore powder capsule. The preparation method comprises the following steps: receiving of raw materials, feeding, crushing, sieving, weighing, mixing, capsule filling, polishing and the like. The capsule provided by the invention has a health-care function of enhancing immunity, is suitable for people with low immunity and has health-care effects of regulating immune function of human body, inhibiting tumor, delaying senescence and the like. In addition, various ingredients supplement each other. The capsule is easy to absorb.
Description
Technical field
The present invention relates to a kind of health products of capsule preparations, particularly a kind of ganoderma spove powder ganoderma lucidum capsule and preparation method thereof.
Background technology
Along with social competition is growing more intense, life and the operating pressure of people are increasing; Meanwhile, environmental pollution is also more and more serious.People are under the double action of intrinsic pressure and external environment, and the physique of people starts to be deteriorated, and often occurs the defect such as flu, indigestion, insomnia, hypertension, high fat of blood.The situation such as immunity degradation, inferior health is more and more common, people need suitable and easily nutrient and healthcare products to improve this situation.
Glossy ganoderma, also known as polyporus lucidus, refreshing sesame, sesame grass, celestial grass, auspicious grass, is the complete stool of the red sesame of Polyporaceae plant or purple sesame.Be best with Ganoderma Sinense drug effect, glossy ganoderma originates in east Asia, distribution in China the widest in Jiangxi, glossy ganoderma is as the Chinese tradition valuable ingredient of traditional Chinese medicine having thousands of years medicinal histories, possesses very high medical value, modern pharmacology research through scientific research institution's many decades confirms, glossy ganoderma, for enhancing body immunity, regulates blood sugar, control blood pressure, adjuvant therapy chemicotherapy, liver protecting, promotes that the aspects such as sleep all have significant curative effect.
Lucidum spore powder is that glossy ganoderma is in the growth and maturity phase, to be hit by a bullet from glossy ganoderma lamella the seed of the extremely small avette reproduction cell that shoots out and glossy ganoderma, it has condensed the elite of glossy ganoderma, have whole inhereditary material and the health-care effect of glossy ganoderma, on average every 100 kilograms of glossy ganodermas just can collect 1 kilogram of pure conidia powder.Lucidum spore powder contains GL-B according to surveying and determination, glossy ganoderma polypeptide, triterpenes, amino acid, protein, aliphatic acid, micro-isoreactivity material, particularly liposoluble substance up to 20%, wherein can be mainly unrighted acid.The size of Reishi sporule only has 5-10 micron; the object of oval shape can be seen under the microscope; it is a living organisms; outer surround by hard chitin fiber element (conidial cell wall); the infringement of this layer of conidial cell wall machinery to external world, physics, chemical factor has good protective effect; be difficult to destroyed, therefore existing lucidum spore powder also exists directly edible not easily by problem that human body is is fully digested and assimilated.
Glossy ganoderma is exactly health-care good product from ancient times, due to fresh glossy ganoderma preservation not easily, and crude glossy ganoderma is not easily absorbed by the body, so there is the processed goods of a lot of glossy ganoderma in the market, and the effect of glossy ganoderma will be bringd into play, need the technique of the formula of science and science to realize.
Summary of the invention
The object of this invention is to provide and a kind ofly can improve body immunity and ganoderma spove powder ganoderma lucidum capsule of good absorbing effect and preparation method thereof.
For achieving the above object, the invention provides a kind of ganoderma spove powder ganoderma lucidum capsule, comprise stock and adjunct, described raw material comprises component Ganodenna Lucidum P.E 65-75 part of following weight portion, ganoderma spove powder 145-155 part, described auxiliary material comprises component dextrin 170-185 part of following weight portion, silica 1 .5-2.5 part.
As the preferred technical solution of the present invention, described raw material comprises the component Ganodenna Lucidum P.E 70 parts of following weight portion, ganoderma spove powder 150 parts, and described auxiliary material comprises 178 parts, the component dextrin of following weight portion, silica 2 parts.
Wherein, the Thick many candies content of described Ganodenna Lucidum P.E is 10%, and the Thick many candies content of described ganoderma spove powder is 2%.
Present invention also offers a kind of preparation method of ganoderma spove powder ganoderma lucidum capsule, comprise the following steps:
1) raw material is got: get in proportion and meet standard, all kinds of raw materials through being up to the standards, comprise Ganodenna Lucidum P.E, sterilized ganoderma spove powder, dextrin and silica;
2) feeding: after each supplementary material removes external packing, inner packing enters 300,000 grades of clean areas by logistics corridor;
3) pulverize, sieve, weigh: Ganodenna Lucidum P.E, ganoderma spove powder, dextrin are pulverized respectively, then 80 mesh sieves are crossed respectively, obtain fine powder, weigh Ganodenna Lucidum P.E fine powder, ganoderma spove powder fine powder, dextrin fine powder and silica by formula rate, for subsequent use;
4) mix: Ganodenna Lucidum P.E fine powder, ganoderma spove powder fine powder and dextrin fine powder are fully mixed 30min, obtains mixed powder, by mixed powder and silica mixing 10min, obtain mixture;
5) filling capsule: by filling for mixture capsule, obtain capsule;
6) polishing: the powder of removing capsule surface;
7) select: select and remove defective capsule;
8) inner packing: 60/bottle;
9) external packing;
10) check;
11) put in storage.
The present invention has the health care of develop immunitypty, is applicable to immunocompromised person, the health-care effect such as have adjusting immunity of human body function, Tumor suppression, delay senility, and various composition complements each other, and is easy to absorb.Wherein the Thick many candies content of sesame extract is 10%, and specification is 10:1, and the Thick many candies content of ganoderma spove powder is 2%, Thick many candies can promote the propagation of Bifidobacterium, suppresses pathogen, prevents constipation, abdominal distension, promote digestion, regulate gastrointestinal function, strengthen immunologic function etc.Ganoderma spove powder ganoderma lucidum capsule instructions of taking of the present invention and dose are oral, every day 2 times, each 3.
Present invention employs preparation section and the parameter of science, nutrition is easy to absorb, and is convenient for carrying.The present invention has and improves function of intestinal canal, the effect of regulating intestinal canal flora, portion of cellulose after dissolving in stomach in ganoderma spove powder can improve function of intestinal canal, cleaning enteron aisle, as promoted intestines peristalsis, get rid of metabolic waste, the present invention simultaneously also has immunity moderation power, regulates blood pressure, blood fat, blood sugar function.
Detailed description of the invention
The following detailed description of the preferred technical solution of the present invention.
Embodiment one
Formula: described raw material comprises Ganodenna Lucidum P.E 67g, ganoderma spove powder 153g, and described auxiliary material comprises dextrin 172g, silica 2.2g.
Each supplementary material is made 1000 (about 0.4g/ grains) altogether above.
Embodiment two
Formula: described raw material comprises Ganodenna Lucidum P.E 73g, ganoderma spove powder 147g, and described auxiliary material comprises dextrin 182g, silica 1 .8g.
Each supplementary material is made 1000 (about 0.4g/ grains) altogether above.
Embodiment three
Formula: described raw material comprises Ganodenna Lucidum P.E 70g, ganoderma spove powder 150g, and described auxiliary material comprises dextrin 178g, silica 2g.
Each supplementary material is made 1000 (about 0.4g/ grains) altogether above.
A preparation method for ganoderma spove powder ganoderma lucidum capsule, comprises the following steps:
1) raw material is got: get in proportion and meet standard, all kinds of raw materials through being up to the standards, comprise Ganodenna Lucidum P.E, sterilized ganoderma spove powder, dextrin and silica;
2) feeding: after each supplementary material removes external packing, inner packing enters 300,000 grades of clean areas by logistics corridor;
3) pulverize, sieve, weigh: Ganodenna Lucidum P.E, ganoderma spove powder, dextrin are pulverized respectively, then 80 mesh sieves are crossed respectively, obtain fine powder, weigh Ganodenna Lucidum P.E fine powder, ganoderma spove powder fine powder, dextrin fine powder and silica by formula rate, for subsequent use;
4) mix: Ganodenna Lucidum P.E fine powder, ganoderma spove powder fine powder and dextrin fine powder are fully mixed 30min, obtains mixed powder, by mixed powder and silica mixing 10min, obtain mixture;
5) filling capsule: by filling for mixture capsule, obtain capsule;
6) polishing: the powder of removing capsule surface;
7) select: select and remove defective capsule;
8) inner packing: 60/bottle;
9) external packing;
10) check;
11) put in storage.
The present invention has the health care of develop immunitypty, is applicable to immunocompromised person, the health-care effect such as have adjusting immunity of human body function, Tumor suppression, delay senility, and various composition complements each other, and is easy to absorb.Wherein the Thick many candies content of sesame extract is 10%, and specification is 10:1, and the Thick many candies content of ganoderma spove powder is 2%, Thick many candies can promote the propagation of Bifidobacterium, suppresses pathogen, prevents constipation, abdominal distension, promote digestion, regulate gastrointestinal function, strengthen immunologic function etc.Ganoderma spove powder ganoderma lucidum capsule instructions of taking of the present invention and dose are oral, every day 2 times, each 3.
Ganodenna Lucidum P.E is the new fresh sporophore of timely collecting maturation, and adopt the techniques such as hot water extraction's (or alcoholic extraction), Vacuum Concentration, spraying dry after oven dry, the glossy ganoderma extract powder obtained is the glossy ganoderma elite that glossy ganoderma powder high power concentrates.
GL-B compounds is important physiologically active ingredient contained by glossy ganoderma, the dark attention by medical sci-tech worker, and GL-B can unlimited, the quick splitting ability of inhibition tumor cell, and at present, GL-B has been used as one of medicine for the treatment of tumour.Now prove: GL-B also has raising immunity of organisms, improve body's hypoxia tolerance, hypoglycemic activity, effect for reducing blood fat, anti-radiation and anti-aging effects.GL-B is the active ingredient extracted from glossy ganoderma, and its effect is remarkable, and health value is high, can as the raw material of all kinds of health products such as GL-B capsule, tablet, electuary, functional food, beverage.
Numerous constituents of Ganodenna Lucidum P.E immunity-regulating system, wherein part is considered to have obvious antitumor properties.In laboratory conditions, in Ganodenna Lucidum P.E, multiple ganoderic acid and polysaccharide display can be used as active AntiHIV1 RT activity material, and show reduce the ability that virus replication reaches 50% under conservative dose, after other east medicinal herbs mixing, glossy ganoderma is used to now to AIDS related complex, the treatment of AIDS, and separately or+mixedly with other medicinal material treat chronic fatigue syndrome.
The main component of ganoderma spove powder is GL-B, the ganoderic acid of triterpenes and natural organic germanium.
Wherein GL-B can strengthen immune function, prevention and therapy tumour and cancer; Reduce blood pressure, prevent the generation of cardiovascular epidemic disease; Stimulate the secretion of insulin, reduce blood sugar concentration; Accelerate blood microcirculation, improve blood oxygen ability, reduce the invalid oxygen demand under body inactive state, eliminate interior free yl, improve the closed stratum of body cell film, anti-radiation, improve liver, marrow, blood synthetic DNA, RNA, the ability of protein, life-extending etc.The multiple pharmacologically active of glossy ganoderma is mostly relevant with GL-B.
The ganoderic acid of triterpenes can improve microcirculation, reduces cholesterol, avoids vascular sclerosis; Strengthen liver, spleen and functions of intestines and stomach, perfect Alimentary running.
Natural organic germanium can strengthen blood of human body keeping amount, promotes hemetaboly, eliminates interior free yl, prevents cell senescence; Can capture electronics from cancer cell, its current potential is declined, thus inhibition cancer cell worsens and diffusion.
Maltodextrin contained in dextrin is made up, not containing the starch derivatives of free starch through minuent hydrolysis, purification, spraying dry of starch.English abbreviation be MD. have that viscosity is large, thickening property is strong, dissolubility is good, instant capacity is good, carrier-mediated good, ferment little, moisture absorption is low, free from extraneous odour, sugariness are low, human body is easy to digest and assimilate, the feature such as low-heat, low fat, it is one of optimal basic material in food industry, can be used as thickener and the stabilizing agent of medicinal sugar, also can be used as excipient and the filler of tablet or electuary.
Silica is mainly used in preventing powdered food from assembling caking in the food industry, to keep a free-pouring based food additive or spices, grease, vitamin etc. for adsorbing liquid state, make it to become Powdered, as the based article of powdered oil, solid spice and solid wine, such as, can be used in milk powder.
Present invention employs preparation section and the parameter of science, nutrition is easy to absorb, and is convenient for carrying.The present invention has and improves function of intestinal canal, the effect of regulating intestinal canal flora, portion of cellulose after dissolving in stomach in ganoderma spove powder can improve function of intestinal canal, cleaning enteron aisle, as promoted intestines peristalsis, get rid of metabolic waste, the present invention simultaneously also has immunity moderation power, regulates blood pressure, blood fat, blood sugar function.
Claims (4)
1. a ganoderma spove powder ganoderma lucidum capsule, it is characterized in that: comprise stock and adjunct, described raw material comprises component Ganodenna Lucidum P.E 65-75 part of following weight portion, ganoderma spove powder 145-155 part, described auxiliary material comprises component dextrin 170-185 part of following weight portion, silica 1 .5-2.5 part.
2. a kind of ganoderma spove powder ganoderma lucidum capsule as claimed in claim 1, it is characterized in that: described raw material comprises the component Ganodenna Lucidum P.E 70 parts of following weight portion, ganoderma spove powder 150 parts, described auxiliary material comprises 178 parts, the component dextrin of following weight portion, silica 2 parts.
3. a kind of ganoderma spove powder ganoderma lucidum capsule as claimed in claim 1, is characterized in that: the Thick many candies content of described Ganodenna Lucidum P.E is 10%, and the Thick many candies content of described ganoderma spove powder is 2%.
4. a preparation method for ganoderma spove powder ganoderma lucidum capsule, is characterized in that comprising the following steps:
1) raw material is got: get in proportion and meet standard, all kinds of raw materials through being up to the standards, comprise Ganodenna Lucidum P.E, sterilized ganoderma spove powder, dextrin and silica;
2) feeding: after each supplementary material removes external packing, inner packing enters 300,000 grades of clean areas by logistics corridor;
3) pulverize, sieve, weigh: Ganodenna Lucidum P.E, ganoderma spove powder, dextrin are pulverized respectively, then 80 mesh sieves are crossed respectively, obtain fine powder, weigh Ganodenna Lucidum P.E fine powder, ganoderma spove powder fine powder, dextrin fine powder and silica by formula rate, for subsequent use;
4) mix: Ganodenna Lucidum P.E fine powder, ganoderma spove powder fine powder and dextrin fine powder are fully mixed 30min, obtains mixed powder, by mixed powder and silica mixing 10min, obtain mixture;
5) filling capsule: by filling for mixture capsule, obtain capsule;
6) polishing: the powder of removing capsule surface;
7) select: select and remove defective capsule;
8) inner packing: 60/bottle;
9) external packing;
10) check;
11) put in storage.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310359889.8A CN104381991A (en) | 2013-08-19 | 2013-08-19 | Ganoderma lucidum sporoderm-broken spore powder capsule and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310359889.8A CN104381991A (en) | 2013-08-19 | 2013-08-19 | Ganoderma lucidum sporoderm-broken spore powder capsule and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104381991A true CN104381991A (en) | 2015-03-04 |
Family
ID=52600039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310359889.8A Pending CN104381991A (en) | 2013-08-19 | 2013-08-19 | Ganoderma lucidum sporoderm-broken spore powder capsule and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104381991A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105012529A (en) * | 2015-08-14 | 2015-11-04 | 慧谷生命科技湖北有限公司 | Ginseng ganoderma lucidum spore powder capsules and preparation method thereof |
| CN105267695A (en) * | 2015-11-17 | 2016-01-27 | 安徽千方生物科技有限公司 | Ganoderma lucidum spore powder compound product for improving anti-tumor curative effects and method for preparing ganoderma lucidum spore powder compound product |
| CN106490587A (en) * | 2016-11-08 | 2017-03-15 | 赵伟 | A kind of preparation method of glossy ganoderma spore powder with crushed sporoderm |
| CN106993800A (en) * | 2016-01-24 | 2017-08-01 | 赵伟 | Selenium-rich ganoderma spove powder production method |
| CN111329954A (en) * | 2020-04-29 | 2020-06-26 | 浙江森芝宝生物科技有限公司 | Ganoderma spore traditional Chinese medicine composition, production equipment and preparation method thereof |
| CN112155199A (en) * | 2020-09-29 | 2021-01-01 | 上海怡宝化妆品集团有限公司 | Capsule containing Ganoderma lucidum sporophore spore powder fermentation liquid and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1363391A (en) * | 2001-01-04 | 2002-08-14 | 李晔 | Garnoderma product and its preparing process |
| CN101524492A (en) * | 2009-04-22 | 2009-09-09 | 完美（中国）日用品有限公司 | Traditional Chinese peroral preparation with immunity-strengthening function and preparation method thereof |
| CN101524377A (en) * | 2009-04-10 | 2009-09-09 | 南京师范大学 | Composite of wall-breaking lucidum spore powder and cyclodextrin and preparation method thereof |
-
2013
- 2013-08-19 CN CN201310359889.8A patent/CN104381991A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1363391A (en) * | 2001-01-04 | 2002-08-14 | 李晔 | Garnoderma product and its preparing process |
| CN101524377A (en) * | 2009-04-10 | 2009-09-09 | 南京师范大学 | Composite of wall-breaking lucidum spore powder and cyclodextrin and preparation method thereof |
| CN101524492A (en) * | 2009-04-22 | 2009-09-09 | 完美（中国）日用品有限公司 | Traditional Chinese peroral preparation with immunity-strengthening function and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 张骠: "《中药复方药效工程学》", 31 March 2005, 中国医药科学出版社 * |
| 齐宪荣 等: "《药剂学和药物化学冲刺宝典》", 31 May 2012, 北京大学医学出版社 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105012529A (en) * | 2015-08-14 | 2015-11-04 | 慧谷生命科技湖北有限公司 | Ginseng ganoderma lucidum spore powder capsules and preparation method thereof |
| CN105267695A (en) * | 2015-11-17 | 2016-01-27 | 安徽千方生物科技有限公司 | Ganoderma lucidum spore powder compound product for improving anti-tumor curative effects and method for preparing ganoderma lucidum spore powder compound product |
| CN106993800A (en) * | 2016-01-24 | 2017-08-01 | 赵伟 | Selenium-rich ganoderma spove powder production method |
| CN106490587A (en) * | 2016-11-08 | 2017-03-15 | 赵伟 | A kind of preparation method of glossy ganoderma spore powder with crushed sporoderm |
| CN111329954A (en) * | 2020-04-29 | 2020-06-26 | 浙江森芝宝生物科技有限公司 | Ganoderma spore traditional Chinese medicine composition, production equipment and preparation method thereof |
| CN112155199A (en) * | 2020-09-29 | 2021-01-01 | 上海怡宝化妆品集团有限公司 | Capsule containing Ganoderma lucidum sporophore spore powder fermentation liquid and preparation method thereof |
| CN112155199B (en) * | 2020-09-29 | 2022-09-23 | 上海洁士宝日化集团有限公司 | Capsule containing Ganoderma lucidum sporophore spore powder fermentation liquid and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104381991A (en) | Ganoderma lucidum sporoderm-broken spore powder capsule and preparation method thereof | |
| CN106954843A (en) | A kind of composite plant enzyme stoste, feature composite plant enzyme stoste and preparation method thereof and functional food | |
| CN106729092A (en) | A kind of blood fat reducing preparation containing xylo-oligosaccharide and its preparation method and application | |
| CN109645200A (en) | A kind of maca pressed candy and preparation method thereof | |
| CN103461631A (en) | Tea sugar food and making method thereof | |
| CN105394252A (en) | Anti-cancer and cancer-preventing probiotic-fermented tea | |
| CN102578646A (en) | Health-care beverage and preparation method thereof | |
| CN106244372A (en) | A kind of ferment Rhizoma Gastrodiae health-preserving beverage improving sleep and preparation technology and application | |
| CN101803769A (en) | Soup base and preparation process thereof | |
| CN101524375A (en) | Wet-process wall breaking method of lucidum spore powder | |
| CN102178217B (en) | Konjac-flour-containing mixture and preparation method thereof | |
| CN104799286B (en) | Composition for improving immunity and preparation method of composition | |
| CN104187681B (en) | A kind of reducing blood sugar and blood fat health food and preparation method thereof | |
| CN102329715A (en) | Compound Rhodiola rosea wine and preparation method thereof | |
| CN106929367A (en) | A kind of lophatherum gracile wine and its process of preparing | |
| CN106581166A (en) | Anti-fatigue food, health product or pharmaceutical composition | |
| CN106038702B (en) | Antifatigue composition and its preparation method and application | |
| CN100346806C (en) | Capsule comprising Chinese caterpillar fungus, royal jelly and matrimony vine | |
| CN102250724A (en) | Cordyceps and ginkgo yellow wine as well as preparation method and application thereof | |
| CN105767310A (en) | Ganoderma-linearstripe rabdosia herb bag tea and preparation method thereof | |
| CN106509578A (en) | Production method of instant ganoderma lucidum-poria cocos compound healthy beverage | |
| CN104161989A (en) | Heart stabilizing polygonatum odoratum-poria cocos-mushroom wine | |
| CN110898180A (en) | Composition for promoting blood circulation, reducing blood fat and losing weight and preparation method thereof | |
| CN111729056A (en) | Anticancer medicine composition and its prepn | |
| CN102726581A (en) | Ganoderma lucidum lipid-lowering tea and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150304 |